Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 100
A novel treatment stratification system for current low- and intermediate-risk neuroblastoma patients using gene expression-based classificationCarolina Sterz, Manuel Fischer, André Oberthuer et al.|Klinische Pädiatrie|2013Cited by 0
Supplementary Table 4 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0